Search - Université de Rennes Access content directly

Filter your results

5 Results
authFullName_s : Behzad Kharabi Masouleh

Drugging the unfolded protein response in acute leukemias

Behzad Kharabi Masouleh , Eric Chevet , Jens Panse , Edgar Jost , Michael O'Dwyer et al.
Journal of Hematology and Oncology, 2015, 8 (1), pp.87. ⟨10.1186/s13045-015-0184-7⟩
Journal articles hal-01187303v1

KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

Bijal D Shah , Armin Ghobadi , Olalekan O Oluwole , Aaron C Logan , Nicolas Boissel et al.
The Lancet, 2021, 398 (10299), pp.491-502. ⟨10.1016/S0140-6736(21)01222-8⟩
Journal articles hal-03260932v1

Updated Outcomes from the Historical Control Study SCHOLAR-3 Contextualizing ZUMA-3 Results of Brexucabtagene Autoleucel (KTE-X19) in Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL)

Bijal Shah , Armin Ghobadi , Olalekan Oluwole , Aaron Logan , Nicolas Boissel et al.
64th ASH Annual Meeting and Exposition, Dec 2022, New Orleans, United States. pp.3158-3161, ⟨10.1182/blood-2022-158248⟩
Conference papers hal-04069384v1

Deregulated expression of the HSP40 family members Auxilin-1 and -2 is indicative of proteostasis imbalance and predicts patient outcome in Ph+ leukemia

Margherita Vieri , Huimin Geng , John B. Patterson , Jens Panse , Stefan Wilop et al.
Experimental Hematology & Oncology, 2016, 5 (1), pp.5. ⟨10.1186/s40164-016-0034-5⟩
Journal articles hal-01274235v1
Image document

Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study

Bijal Shah , Armin Ghobadi , Olalekan Oluwole , Aaron Logan , Nicolas Boissel et al.
Journal of Hematology and Oncology, 2022, 15 (1), pp.170. ⟨10.1186/s13045-022-01379-0⟩
Journal articles hal-04069449v1